SQUAMOUS CELL CARCINOMA OF THE PAROTID GLAND

SQUAMOUS CELL CARCINOMA OF THE PAROTID GLAND was reported 19 times

SQUAMOUS CELL CARCINOMA OF THE PAROTID GLAND is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Endoglycosidase [EPC] 1 0.0005
1 CD38-directed Cytolytic Antibody [EPC] 1 0.0002
2 Adenosine Receptor Agonist [EPC] 1 0.0001
3 SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] 1 0.0001
4 Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1 0.0000
5 Interleukin-17A Antagonist [EPC] 1 0.0000
6 Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 1 0.0000
7 5-alpha Reductase Inhibitor [EPC] 2 0.0000
8 Peroxisome Proliferator Receptor alpha Agonist [EPC] 1 0.0000
9 Vitamin D [EPC] 5 0.0000
10 BCL-2 Inhibitor [EPC] 1 0.0000
11 Vitamin B12 [EPC] 5 0.0000
12 Janus Kinase Inhibitor [EPC] 2 0.0000
13 Vitamin C [EPC] 5 0.0000
14 Folate Analog Metabolic Inhibitor [EPC] 5 0.0000
15 Expectorant [EPC] 2 0.0000
16 Interleukin-23 Antagonist [EPC] 1 0.0000
17 Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 1 0.0000
18 Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1 0.0000
19 Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1 0.0000
20 Sulfonylurea [EPC] 1 0.0000
21 Calcineurin Inhibitor Immunosuppressant [EPC] 1 0.0000
22 Azole Antifungal [EPC] 1 0.0000
23 Phosphodiesterase 4 Inhibitor [EPC] 1 0.0000
24 Xanthine Oxidase Inhibitor [EPC] 1 0.0000
25 Corticosteroid [EPC] 6 0.0000
26 Factor Xa Inhibitor [EPC] 1 0.0000
27 Kinase Inhibitor [EPC] 2 0.0000
28 Osmotic Laxative [EPC] 1 0.0000
29 Loop Diuretic [EPC] 1 0.0000
30 Thalidomide Analog [EPC] 1 0.0000
31 Platelet Aggregation Inhibitor [EPC] 1 0.0000
32 Nonsteroidal Anti-inflammatory Drug [EPC] 1 0.0000